Transcranial Direct Current to Treat Epilepsy at Home

Running, not enrolling · Not applicable · Has a placebo group

Conditions studied: Epilepsies, Partial

In brief

This is a placebo-controlled study of feasibility and potential effectiveness of transcranial direct current stimulation (tDCS) in the home environment to reduce seizures and EEG spikes.

Key facts

Study ID

NCT04309812

Run by

Stanford University

People needed

4

Starts

2021-05-26

Expected to finish

2027-06-30

Last updated by the study team

2026-02-27

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-100, inclusive.
• Has a clinical diagnosis of epilepsy
• Has at least 4 countable seizures per month
• Has not had control with at least 2 anti-seizure medicines
• Able to maintain a constant medication for duration of the study (rescue meds allowed)
• Subject or legally authorized representative is able to understand consent and keep a seizure diary in English

You may not qualify if…

• A disease likely to progress over course of the study
• Psychogenic non-epileptic seizures
• Suicide attempt or psychiatric hospitalization past 2 years
• A skin condition interfering with scalp electrodes or allergy to silver
• Women will verify not pregnant, and if applicable, have a serum pregnancy test

Where it is running

• Stanford Hospital — Stanford, California, United States
• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.